eligibility for clinicaltrials:NCT00006034 [clinicaltrials_resource:e38644c6295670598693e0940c281115]
eligibility [clinicaltrials_vocabulary:eligibility]
eligibility for clinicaltrials:NCT00006034 [clinicaltrials_resource:e38644c6295670598693e0940c281115]
Bio2RDF identifier
e38644c6295670598693e0940c281115
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:e38644c6295670598693e0940c281115
gender [clinicaltrials_vocabulary:gender]
healthy volunteers [clinicaltrials_vocabulary:healthy-volunteers]
minimum age [clinicaltrials_vocabulary:minimum-age]
text [clinicaltrials_vocabulary:text]
DISEASE CHARACTERISTICS:
...... toxic immunosuppressive agents
identifier
clinicaltrials_resource:e38644c6295670598693e0940c281115
title
eligibility for clinicaltrials:NCT00006034
@en
type
label
eligibility for clinicaltrials ...... 644c6295670598693e0940c281115]
@en